Human Metabolome Technologies, Inc. (6090.T)
JPY 604.0
(0.0%)
JPY 604.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 236.79 Million | 284.96 Million | 324.03 Million | -34.17 Million | 184.07 Million |
| Net Income | 243.24 Million | 237 Million | 261.91 Million | 50.94 Million | -24.54 Million |
| Depreciation & Amortization | 86.31 Million | 80.38 Million | 64.89 Million | 55.84 Million | 47.96 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 473 Thousand | 1.13 Million | 3.16 Million | 24.12 Million |
| Change in working capital | -75.83 Million | 9.77 Million | 68.74 Million | -82.24 Million | 110.59 Million |
| Other non-cash items | 247.52 Million | -21.46 Million | -26.2 Million | -32.34 Million | 9.34 Million |
| Investing Cash Flow | -32.44 Million | -116.75 Million | -152.31 Million | -25.98 Million | -34.93 Million |
| Investments in PPE | -34.09 Million | -116.85 Million | -146.11 Million | -27.86 Million | -34.84 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | -7 Million | - | - |
| Sales/Maturities of investments | - | 100 Thousand | - | - | - |
| Other Investing Activities | 1.65 Million | -18 Million | 800 Thousand | 1.88 Million | -95 Thousand |
| Financing Cash Flow | -73.15 Million | -13.75 Million | 80.49 Million | 86.21 Million | 22.09 Million |
| Debt repayment | -14.45 Million | -13.73 Million | -100 Million | -100 Million | -9.63 Million |
| Dividends payments | -58.69 Million | - | - | - | - |
| Common Stock Repurchased | - | -23 Thousand | - | - | -76 Thousand |
| Common Stock Issuance | - | - | - | 3 Million | 31.81 Million |
| Other Financing Activities | -1000.00 | -1000.00 | -1000.00 | 86 Million | -1000.00 |
| Accounts receivables | -96.09 Million | 29 Million | -1 Million | -82 Million | 3 Million |
| Accounts payables | 15.03 Million | -123 Thousand | -146 Thousand | -8.04 Million | 8.25 Million |
| Inventory | -10.77 Million | 17.18 Million | -8.6 Million | 35.84 Million | -15.8 Million |
| Other working capital | 15.99 Million | -19 Million | -38 Million | -19 Million | 102 Million |
| Cash at beginning of period | 1.65 Billion | 1.5 Billion | 1.24 Billion | 1.21 Billion | 1.04 Billion |
| Cash at end of period | 1.78 Billion | 1.65 Billion | 1.5 Billion | 1.24 Billion | 1.21 Billion |
| Capital Expenditure | -34.09 Million | -116.85 Million | -146.11 Million | -27.86 Million | -34.84 Million |
| Effect of forex changes on cash | 516 Thousand | -2.4 Million | 7.48 Million | -33 Thousand | -638 Thousand |
| Net cash flow / Change in cash | 131.71 Million | 152.04 Million | 259.69 Million | 26.02 Million | 170.59 Million |
| Free Cash Flow | 202.69 Million | 168.1 Million | 177.91 Million | -62.04 Million | 149.23 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 15 Million | 243.24 Million | 157 Million | 109 Million | -38 Million | 237 Million |
| Depreciation & Amortization | - | 86.31 Million | - | - | - | 80.38 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 473 Thousand |
| Change in working capital | - | -75.83 Million | - | - | - | 9.77 Million |
| Other non-cash items | -15 Million | 247.52 Million | -157 Million | -109 Million | 38 Million | -21.46 Million |
| Investing Cash Flow | - | -32.44 Million | - | - | - | -116.75 Million |
| Investments in PPE | - | -34.09 Million | - | - | - | -116.85 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 100 Thousand |
| Other Investing Activities | - | 1.65 Million | - | - | - | -18 Million |
| Financing Cash Flow | - | -73.15 Million | - | - | - | -13.75 Million |
| Debt repayment | - | -14.45 Million | - | - | - | -13.73 Million |
| Dividends payments | - | -58.69 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -23 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -1000.00 |
| Accounts receivables | - | -96.09 Million | - | - | - | 29 Million |
| Accounts payables | - | 15.03 Million | - | - | - | -123 Thousand |
| Inventory | - | -10.77 Million | - | - | - | 17.18 Million |
| Other working capital | - | 15.99 Million | - | - | - | -19 Million |
| Cash at beginning of period | - | 1.65 Billion | - | - | - | 1.5 Billion |
| Cash at end of period | - | 1.78 Billion | - | - | - | 1.65 Billion |
| Capital Expenditure | - | -34.09 Million | - | - | - | -116.85 Million |
| Effect of forex changes on cash | - | - | - | - | - | -2.4 Million |
| Net cash flow / Change in cash | - | 131.71 Million | - | - | - | 152.04 Million |
| Free Cash Flow | - | 202.69 Million | - | - | - | 168.1 Million |
1082
1472
USB-PH
6141
GMGI
SCI